Article Text

Download PDFPDF
Towards a bioethics of innovation
  1. Wendy Lipworth1,
  2. Renata Axler2
  1. 1University of Sydney, Sydney, Australia
  2. 2University of Toronto, Toronto, Canada
  1. Correspondence to Dr Wendy Lipworth, Centre for Values, Ethics and the Law in Medicine, Medical Foundation Building (K25), University of Sydney, NSW 2006 Australia; wendy.lipworth{at}


In recent years, it has become almost axiomatic that biomedical research and clinical practice should be ‘innovative’—that is, that they should be always evolving and directed towards the production, translation and implementation of new technologies and practices. While this drive towards innovation in biomedicine might be beneficial, it also raises serious moral, legal, economic and sociopolitical questions that require further scrutiny. In this article, we argue that biomedical innovation needs to be accompanied by a dedicated ‘bioethics of innovation’ that attends systematically to the goals, process and outcomes of biomedical innovation as objects of critical inquiry. Using the example of personalised or precision medicine, we then suggest a preliminary framework for a bioethics of innovation, based on the research policy initiative of ‘Responsible Innovation’. We invite and encourage critiques of this framework and hope that this will provoke a challenging and enriching new bioethical discourse.

  • Applied and Professional Ethics
  • Technology/Risk Assessment
  • Public Policy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you